Ashraf A. Khalil

498 total citations
26 papers, 412 citations indexed

About

Ashraf A. Khalil is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ashraf A. Khalil has authored 26 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Ashraf A. Khalil's work include Cancer-related Molecular Pathways (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Synthesis and biological activity (3 papers). Ashraf A. Khalil is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Synthesis and biological activity (3 papers). Ashraf A. Khalil collaborates with scholars based in United States, Egypt and Saudi Arabia. Ashraf A. Khalil's co-authors include Mark J. Jameson, Gomaa El Fawal, Sahar F. Deraz, Hussein I. El‐Subbagh, William C. Broaddus, Abdulrahman M. Al‐Obaid, Theodore D. Chung, Peck Sun Lin, Doaa A. Ghareeb and Sarah E. Golding and has published in prestigious journals such as The Laryngoscope, Enzyme and Microbial Technology and Journal of Natural Products.

In The Last Decade

Ashraf A. Khalil

26 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf A. Khalil United States 14 161 96 57 54 51 26 412
Piroska Virág Romania 15 149 0.9× 101 1.1× 35 0.6× 48 0.9× 127 2.5× 37 553
Xiaoyuan Zhang China 13 350 2.2× 113 1.2× 42 0.7× 40 0.7× 51 1.0× 37 629
Yunyun Wu China 13 182 1.1× 60 0.6× 40 0.7× 46 0.9× 36 0.7× 38 531
Claudia Popa Romania 12 267 1.7× 35 0.4× 47 0.8× 71 1.3× 94 1.8× 23 525
Diana Aparecida Dias Câmara Brazil 9 211 1.3× 41 0.4× 33 0.6× 39 0.7× 49 1.0× 17 472
Biswa Prasun Chatterji India 9 316 2.0× 87 0.9× 24 0.4× 76 1.4× 86 1.7× 18 536
Aline Beckenkamp Brazil 13 170 1.1× 39 0.4× 23 0.4× 81 1.5× 108 2.1× 20 435
Kozue Yoshida Japan 10 145 0.9× 37 0.4× 40 0.7× 107 2.0× 28 0.5× 26 432

Countries citing papers authored by Ashraf A. Khalil

Since Specialization
Citations

This map shows the geographic impact of Ashraf A. Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf A. Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf A. Khalil more than expected).

Fields of papers citing papers by Ashraf A. Khalil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf A. Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf A. Khalil. The network helps show where Ashraf A. Khalil may publish in the future.

Co-authorship network of co-authors of Ashraf A. Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf A. Khalil. A scholar is included among the top collaborators of Ashraf A. Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf A. Khalil. Ashraf A. Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aissouq, Abdellah El, et al.. (2025). 2D QSAR, Design, ADMET Prediction, and Docking Study of Novel Coumarin Derivatives as α-Glucosidase Inhibitors. Russian Journal of General Chemistry. 95(5). 1007–1024. 1 indexed citations
2.
Khalil, Ashraf A., Mark J. Axelrod, Abel P. David, et al.. (2019). Antitumor effect of insulin‐like growth factor‐1 receptor inhibition in head and neck squamous cell carcinoma. The Laryngoscope. 130(6). 1470–1478. 5 indexed citations
3.
Allak, Amir, et al.. (2019). Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells. Frontiers in Oncology. 9. 13–13. 8 indexed citations
4.
Khalil, Ashraf A. & Mark J. Jameson. (2018). Downregulation of IGF1R Expression Inhibits Growth and Enhances Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cells In Vitro. Hormones and Cancer. 10(1). 11–23. 8 indexed citations
5.
Khalil, Ashraf A. & Mark J. Jameson. (2017). Sodium orthovanadate inhibits proliferation and triggers apoptosis in oral squamous cell carcinoma in vitro. Biochemistry (Moscow). 82(2). 149–155. 22 indexed citations
6.
Khalil, Ashraf A. & Mark J. Jameson. (2017). The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro. Drugs in R&D. 17(4). 545–555. 28 indexed citations
7.
8.
Moudgil, Kamal D. & Ashraf A. Khalil. (2016). The 1st Euro-Mediterranean Workshop: Natural Products in Health and Diseases: Cairo, Egypt, March 2, 2015. Asian Journal of Pharmaceutical Sciences. 11(2). 292–296. 2 indexed citations
9.
Khalil, Ashraf A., et al.. (2014). Enhancement of Mechanical Properties, Microstructure, and Antimicrobial Activities of Zein Films Cross-Linked Using Succinic Anhydride, Eugenol, and Citric Acid. Preparative Biochemistry & Biotechnology. 45(6). 551–567. 50 indexed citations
10.
Khalil, Ashraf A., et al.. (2014). Nanoimmunoassay to Detect Responses in Head and Neck Cancer: Feasibility in a Mouse Model. Otolaryngology. 151(1). 92–99. 1 indexed citations
11.
Axelrod, Mark J., Ashraf A. Khalil, Stephanie Leimgruber, et al.. (2014). Synergistic apoptosis in head and neck squamous cell carcinoma cells by co‐inhibition of insulin‐like growth factor‐1 receptor signaling and compensatory signaling pathways. Head & Neck. 37(12). 1722–1732. 6 indexed citations
12.
Badr, M., et al.. (2013). Design, Synthesis and Evaluation of some Novel Pyrazoline Derivatives as Potential Anti-inflammatory and Antitumor Agents. Drug Research. 63(6). 271–281. 3 indexed citations
13.
Khalil, Ashraf A., Mark J. Jameson, William C. Broaddus, et al.. (2013). The Influence of Hypoxia and pH on Bioluminescence Imaging of Luciferase-Transfected Tumor Cells and Xenografts. PubMed. 2013. 1–9. 30 indexed citations
14.
Khalil, Ashraf A., Mark J. Jameson, William C. Broaddus, Peck Sun Lin, & Theodore D. Chung. (2012). Nicotine enhances proliferation, migration, and radioresistance of human malignant glioma cells through EGFR activation. Brain Tumor Pathology. 30(2). 73–83. 38 indexed citations
15.
Diwani, G. El, et al.. (2012). Recovery of Phorbol from Oil of an Egyptian Jatropha. Asian Journal of Plant Sciences. 11(3). 117–123. 3 indexed citations
16.
Soliman, Emad A., et al.. (2012). Synthesis, characterization and antibacterial activity of biodegradable films prepared from Schiff bases of zein. Journal of Food Science and Technology. 51(10). 2425–2434. 25 indexed citations
17.
Sayed, Khalid A. El, Ashraf A. Khalil, Muhammad Yousaf, et al.. (2008). Semisynthetic Studies on the Manzamine Alkaloids. Journal of Natural Products. 71(3). 300–308. 21 indexed citations
18.
Khalil, Ashraf A., et al.. (2003). Substituted Quinazolines, Part 2. Synthesis and In‐Vitro Anticancer Evaluation of New 2‐Substituted Mercapto‐3H‐quinazoline Analogs. Archiv der Pharmazie. 336(2). 95–103. 46 indexed citations
20.
El-Obeid, Humeida A., et al.. (2001). Substituted Quinazolines, 1. Synthesis and Antitumor Activity of Certain Substituted 2-Mercapto-4(3H)-quinazolinone Analogs. Scientia Pharmaceutica. 69(4). 351–366. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026